Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy

Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy,a Randomized Clinical Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03456258

Acronym

Lactoferrin

Enrollment

100

Registered

2018-03-07

Start date

2017-09-05

Completion date

2018-01-15

Last updated

2018-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency Anemia of Pregnancy

Brief summary

The study aims to compare the efficacy and the safety of Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy.

Detailed description

The study was done at ainshams university maternity hospital on 100 pregnant women randomized in two groups . Group one lactoferrin group Group two ferrous sulphate group

Interventions

DIAGNOSTIC_TESTComplete blood count

To measure hemoglobin difference and serum ferritin levels .

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* pregnant women from 20 to 40 years * iron deficiency anemia (mild and moderate) * gestational age 13 to 26 weeks * singleton viable pregnancy.

Exclusion criteria

* history of anemia due to chronic blood loss * hemolytic anemia * severe anemia * history of peptic ulcer

Design outcomes

Primary

Measure	Time frame	Description
hemoglobin level	2 months	Measure hemoglobin level two months after treatment

Secondary

Measure	Time frame	Description
Serum ferritin	2 months	Measure serum ferritin level

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026